Total IgE variability is associated with future asthma exacerbations: a one-year prospective cohort study.

May 17, 2021

Contributor: Yu Lai Yuan,Xin Zhang,Lei Liu,Gang Wang,Alan Chen-Yu Hsu,Dan Huang,Gang Wang,Brian G Oliver

Total IgE variability is associated with future asthma exacerbations: a one-year prospective cohort study.

Few prospective studies have investigated the relationship between IgE variability and risk of asthma exacerbations (AEs).
To explore the relationship between IgE variability and AEs.
Recruited patients with stable asthma underwent two serum total IgE tests within a month (at screening [baseline IgE] and one-month) to obtain coefficient of variation (CV) of base-10 log-transformed IgE. Patients with IgE CV were divided into IgE CV-high and IgE CV-low cohorts based on the CV’s median and followed up within a 12-month period during which, the association between IgE variability and AEs was explored using a negative binomial regression model.
IgE CV levels obtained from 340 patients classified the patients into two groups (n=170 for the IgE CV-high and IgE CV-low groups, respectively) based on the serum total IgE CV median of 2.12% (Q1, Q3: 0.98%, 3.91%). IgE CV-high patients exhibited worse asthma control and lung function, more marked airway inflammation, and received more intensive medication use compared to IgE CV-low patients. IgE CV-high patients exhibited increased rates of moderate-to-severe (adjusted rate ratio [RR]=2.88, 95% CI=[1.65, 5.03], P<0.001) and severe (RR=2.16, 95% CI=[1.08, 4.32], P=0.029) AEs during the follow-up year compared to IgE CV-low patients. Furthermore, sputum IL-6 partially mediated the associations between IgE CV with moderate-to-severe and severe AEs.
Variability in total serum IgE levels is an easily obtained and practical measure for predicting AEs. Future studies are needed to investigate whether IgE variability can be used to guide precision medicine in asthma.

Copyright © 2021. Published by Elsevier Inc.

Author

admin

View all posts

About The Expert

Yu Lai Yuan

Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Department of Respiratory Medicine, Traditional Chinese Medicine Hospital Affiliated to Southwest Medical University, Luzhou 646000, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, PR China; West China School of Medicine, Sichuan University, Chengdu 610041, PR China.

Xin Zhang

Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, PR China.

Lei Liu

Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, PR China; West China School of Medicine, Sichuan University, Chengdu 610041, PR China.

Gang Wang

Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, PR China; West China School of Medicine, Sichuan University, Chengdu 610041, PR China; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Alan Chen-Yu Hsu

Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New Lambton Heights, NSW 2305, Australia.

Dan Huang

Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, PR China; West China School of Medicine, Sichuan University, Chengdu 610041, PR China.

Gang Wang

Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, PR China. Electronic address: wcums-repiration@hotmail.com.

Brian G Oliver

Airway Physiology and Imaging Group and the Woolcock Emphysema Centre, The Woolcock Institute of Medical Research, Sydney, NSW, Australia; Discipline of Medical Sciences, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia.

References

PubMed